Many countries can still access some of these medicine donations in bottles (DEC, IVM, ALB, and AZM for trachoma). However, as companies move to restrict their donations (either to areas with prevalence above a defined threshold or to low-income countries and away from middle-income countries), certain countries and organizations wish to procure their own medicines and prefer blister packaging. Unlike free bottled medicines, or no medicines at all, Bend Biomedical uses the appropriate dosage forms, optimal packaging, and labels and instructions in the local language.


Blister-Packaged Tablets:


Diethylcarbamazine (DEC) for lymphatic filariasis and tropical pulmonary eosinophilia


100 mg tiny tablet


Ivermectin (IVM) for onchocerciasis, lymphatic filariasis, scabies, strongyloidiasis, mansonelliasis, and malaria transmission


3 mg dissolvable (peel-drop)


Albendazole (ALB) for soil transmitted helminths (ascariasis, trichuriasis, and hookworm infection), lymphatic filariasis, oesophagostomiasis, and strongyloidiasis


400 mg chewable


Praziquantel (PZQ) for female genital schistosomiasis, foodborne trematodiases, and taeniasis


600 mg systemic


Iron and Folic Acid (IFA) for neural tube defects (spina bifida, anencephaly, and encephalocele), atherosclerosis, stunting, low birth weight, preterm birth, and perinatal mortality


60 mg of iron and .4 mg of folic acid

Powder and Solvent for Suspension for Injection:


Benzathine Penicillin (BPG) for congenital syphilis, rheumatic heart disease, erysipelas, yaws, and pinta


1.2M U IM and 2.4 U IM vials

Blister-Packaged Soft Gelatin Capsules:


Vitamin A (Vit A) for blindness and related mortality, respiratory disease, and other infections


100,000 IU and 200,000 IU liquids

Blister-Packaged Film-Coated Tablets for Oral Suspension:


Azithromycin (AZM) for trachoma and yaws


20 mg/kg for children, 1 g for adults. Tablet is 262.05 mg, equivalent to 250 mg azithromycin base



Azithromycin (AZM) as above but packaged for infants for under-five mortality prevention

Blister-Packaged Fixed-Dose Combination Tablets:


Piperaquine/dihydroartemisinin (DHA-PPQ) for uncomplicated falciparum malaria


20 mg DHA/160 mg PPQ and 40 mg DHA/320 mg PPQ tablets


Drugs and diseases are listed for informational purposes only. Consult your local medical authority for advice.

The usual approach to community-based mass drug administration and other critical preventive medicines is for tablets to be distributed from shared bottles without labels or instructions. As a result, patients have a lack of trust and effective coverage is poor. Today, Bend Biomedical blister-packaged medicines are attractive for both low- and middle-income countries. Our packaging model can be used to provide critically needed medicines for neglected populations around the world.


We participate in a process known as World Health Organization (WHO) prequalification of medicines, a service provided by WHO to assess the quality, safety, and efficacy of medicinal products. Only essential medicines qualify. Countries and organizations now express a preference for WHO prequalified medicines. At Bend Biomedical, we either package in the United States the original name-brand drug, or we use a contract manufacturing organization to manufacture and package a WHO prequalified generic with the same quality and performance as the original drug.